Company intelligence / Profile preview

DRG International

Springfield Township, New Jersey, USA

Ownership: Private
Development stage: Other

Overview

DRG International is a globally active diagnostics company acquired by BioCheck in 2021, offering >200 FDA-approved products, mainly ELISA/IVD immunoassays, with global distribution for diagnostics in oncology, endocrinology, cardiology, infectious diseases, and more. Diagnostic kits are recognized for reliable and reproducible results and serve clinical and research labs in over 110 countries.

Therapeutic areas: CardiovascularEndocrinologyGastroenterologyInfectious DiseasesWomen's HealthOncology
Modalities: ImmunoassayELISAChemiluminescent assay
Industry: Protein Biomarker Diagnostics

Partnerships

BioCheck (parent company, technology sharing)CHROMagar (authorized US distributor)

Beyond the preview

Go deeper on DRG International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DRG International.

Explore the full profile